Heartflow has closed a $215M Series F funding round to provide AI-powered personalized cardiac health tests.
The company's solutions are used in 725 hospital systems and over 180,000 patient scans in the U.S.
- Heatrtflow
offers artificial intelligence-powered software that maps out the
heart's coronary arteries and any potential blockages.
- The company provides FDA-approved solutions for coronary artery anatomy, physiology, and plaque information, based on CCTA.
- Heartflow aims to use the funding round to boost production and invest in research.
- Bain
Capital Life Sciences led the funding round, with participation from
Janus Henderson Investors, Capricorn Investment Group, Hayfin Capital
Management, HealthCor, Martis Capital, USVP, and Wellington Management.
- Since its inception in 2007, the company has raised around $800M.
- The company is based in Mountain View, California.
